Combining Adaptive Designs With Enrichment Strategies
Executive Summary
FDA draft guidance explains how adaptive trial designs can help implement enrichment strategies when there is uncertainty about a predictive marker’s power.
You may also be interested in...
Simulation Of Clinical Scenarios Important To Support Adaptive Trial Designs
FDA has approved one drug supported by an adaptive design, but the trial did not save money or time, FDA statistician tells regulatory professionals.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.